Dr Waltin Zomaya, PHARMD in Dumas, AR - Pharmacist

Dr Waltin Zomaya, PHARMD is a Pharmacist based in Dumas, Arkansas. Dr Waltin Zomaya is licensed to practice in Arkansas (license number PD14187) and his current practice location is 301 Highway 65 S, Dumas, Arkansas. He can be reached at his office (for appointments etc.) via phone at (870) 382-0500.

NPI number for Dr Waltin Zomaya is 1841888294 and his current mailing address is 301 Highway 65 S, Dumas, Arkansas. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1841888294.

Contact Information

	Dr Waltin Zomaya, PHARMD
	301 Highway 65 S, Dumas, AR 71639-2335
	(870) 382-0500
	Not Available

Healthcare Provider's Profile

Full Name	Dr Waltin Zomaya
Gender	Male
Speciality	Pharmacist
Location	301 Highway 65 S, Dumas, Arkansas
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1841888294
Provider Enumeration Date: 12/31/2020
Last Update Date: 12/31/2020

Medical Identifiers

Medical identifiers for Dr Waltin Zomaya such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1841888294	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
183500000X	Pharmacist	PD14187 (Arkansas)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Waltin Zomaya is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Waltin Zomaya, PHARMD 301 Highway 65 S, Dumas, AR 71639-2335 Ph: (870) 382-0500	Dr Waltin Zomaya, PHARMD 301 Highway 65 S, Dumas, AR 71639-2335 Ph: (870) 382-0500

News Archive

Generex Biotechnology, Seaside 88 close first tranche of 2 million shares for gross proceeds of $945,180

Generex Biotechnology Corporation, the leader in drug delivery for metabolic diseases through the inner lining of the mouth, today announced that it has entered into a common stock purchase agreement with Seaside 88, LP, a private investment limited partnership. Seaside has committed to purchase up to 49,455,130 shares of Generex common stock.

Today's OpEds: The Berwick backlash; HIV screening a part of routine care; And why Congress should provide Medicaid help to states

As is well-known, Congress has a constitutional duty to examine presidential nominees like Dr. Berwick. But apparently, the prospect of giving the American people an opportunity to hear this nominee defend his past praise for government-run systems that ration healthcare was worrisome enough for the administration that it sought to ignore congressional oversight altogether (Sen. Mitch McConnell, 7/12).

Stopping antiretroviral therapy in HIV-infected patients could be beneficial

Stopping antiretroviral therapy in HIV-infected patients from time to time could reduce the side effects and costs of the treatment, according to a study in this week's issue of The Lancet.

Researchers take major step forward in developing real ALS treatments

A series of studies begun by Harvard Stem Cell Institute scientists eight years ago has lead to a report published today that may be a major step forward in the quest to develop real treatments for amyotrophic lateral sclerosis, ALS, or Lou Gehrig's disease.

Study: CIEDs used by physicians today were approved as supplements to premarket approved models

The Food and Drug Administration (FDA) ensures that high-risk medical devices, such as implantable cardioverter-defibrillators and pacemakers, are safe and effective through its premarket approval (PMA) pathway, during which manufacturers must collect preclinical and clinical data before the device is approved.

Pharmacist in Dumas, AR

Mr. Eugene H Lee, Jr, PHARMACIST Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 105 W Choctaw St, Dumas, AR 71639 Phone: 870-382-4007 Fax: 870-382-4008
Dr. Cheryl R. Stimson, P.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 301 Highway 65 S, Dumas, AR 71639 Phone: 870-382-0500 Fax: 870-382-6709
William Clay Canada Jr., R PH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 101 W Waterman St, Dumas, AR 71639 Phone: 870-382-4343
Dr. Tammy L. Kellebrew, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 12 Porter St, Dumas, AR 71639 Phone: 870-814-3399
Megan French, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 393 Independence Ln, Dumas, AR 71639 Phone: 870-382-0500

Dr Waltin Zomaya, PHARMD - Pharmacist in Dumas, AR